Gavilimomab

Gavilimomab
Trade Name
Orphan Indication Graft Versus Host Disease
USA Market Approval USA
USA Designation Date 2000-11-20 00:00:00
Sponsor Amgen;One Amgen Center Drive, Mail Stop 17-2-A;Thousand Oaks, California, 91320